162 related articles for article (PubMed ID: 25283056)
1. Griscelli syndrome type 3-like phenotype with MYO-5A exon-F deletion.
Yılmaz M; Çağdaş D; Grandin V; Altıntaş DU; Tezcan İ; de Saint Basile G; Sanal Ö
Pediatr Allergy Immunol; 2014 Dec; 25(8):817-9. PubMed ID: 25283056
[No Abstract] [Full Text] [Related]
2. Genetic analysis in three Egyptian patients with Griscelli syndrome Type 1 reveals new nonsense mutations in MYO5A.
Abd Elmaksoud MS; Gomaa NS; Azouz HG; On CNV; Ho CT; Omar TE; McGrath JA; Onoufriadis A
Clin Exp Dermatol; 2020 Aug; 45(6):789-792. PubMed ID: 32275080
[No Abstract] [Full Text] [Related]
3. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).
Ménasché G; Ho CH; Sanal O; Feldmann J; Tezcan I; Ersoy F; Houdusse A; Fischer A; de Saint Basile G
J Clin Invest; 2003 Aug; 112(3):450-6. PubMed ID: 12897212
[TBL] [Abstract][Full Text] [Related]
4. Griscelli syndrome types 1 and 3: analysis of four new cases and long-term evaluation of previously diagnosed patients.
Cağdaş D; Ozgür TT; Asal GT; Tezcan I; Metin A; Lambert N; de Saint Basile G; Sanal O
Eur J Pediatr; 2012 Oct; 171(10):1527-31. PubMed ID: 22711375
[TBL] [Abstract][Full Text] [Related]
5. Griscelli syndrome type 3 in Ethiopian sisters resulting from a homozygous missense mutation in MLPH.
Dagnewu KY; Ayele A; Liu L; Pramanik R; Onoufriadis A; Abebe E; McGrath JA
Int J Dermatol; 2020 Mar; 59(3):e55-e57. PubMed ID: 31721180
[No Abstract] [Full Text] [Related]
6. A RAB27A duplication in several cases of Griscelli syndrome type 2: An explanation for cases lacking a genetic diagnosis.
Grandin V; Sepulveda FE; Lambert N; Al Zahrani M; Al Idrissi E; Al-Mousa H; Almanjomi F; Al-Ghonaium A; K Habazi M; A Alghamdi H; Picard C; Bole-Feysot C; Nitschke P; Ménasché G; de Saint Basile G
Hum Mutat; 2017 Oct; 38(10):1355-1359. PubMed ID: 28585352
[TBL] [Abstract][Full Text] [Related]
7. Griscelli syndrome.
Emanuel PO; Sternberg LJ; Phelps RG
Skinmed; 2007; 6(3):147-9. PubMed ID: 17483661
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for genotype-phenotype disparity in Griscelli syndrome.
Lee JYW; Eldeeb MS; Hsu CK; Saito R; Abouzeid SA; McGrath JA
Br J Dermatol; 2017 Apr; 176(4):1086-1089. PubMed ID: 27416802
[No Abstract] [Full Text] [Related]
9. [Griscelli syndrome type 3: A new case].
Kassem Youssef H; Ramstein C; Ginglinger E; Chouta Ngaha F; Nojavan H; Michel C
Ann Dermatol Venereol; 2018 Dec; 145(12):785-789. PubMed ID: 30389201
[TBL] [Abstract][Full Text] [Related]
10. Rab27b is up-regulated in human Griscelli syndrome type II melanocytes and linked to the actin cytoskeleton via exon F-Myosin Va transcripts.
Westbroek W; Lambert J; De Schepper S; Kleta R; Van Den Bossche K; Seabra MC; Huizing M; Mommaas M; Naeyaert JM
Pigment Cell Res; 2004 Oct; 17(5):498-505. PubMed ID: 15357836
[TBL] [Abstract][Full Text] [Related]
11.
Christen M; de le Roi M; Jagannathan V; Becker K; Leeb T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680875
[TBL] [Abstract][Full Text] [Related]
12. [Griscelli syndrome].
Teran CG; Issrael Asbun E; Villarroel Arratia P; Teran Escalera CN
An Pediatr (Barc); 2008 May; 68(5):532-3. PubMed ID: 18448007
[No Abstract] [Full Text] [Related]
13. Novel homozygous nonsense variant in MLPH causing Griscelli syndrome type 3 in a consanguineous Pakistani family.
Wasif N; Parveen A; Bashir H; Ashraf F; Ali E; Khan KR; Arif A
J Dermatol; 2020 Nov; 47(11):e382-e383. PubMed ID: 32864751
[No Abstract] [Full Text] [Related]
14. Griscelli Syndrome Type 3: Two New Cases and Review of the Literature.
Nouriel A; Zisquit J; Helfand AM; Anikster Y; Greenberger S
Pediatr Dermatol; 2015; 32(6):e245-8. PubMed ID: 26337734
[TBL] [Abstract][Full Text] [Related]
15. Two genes are responsible for Griscelli syndrome at the same 15q21 locus.
Pastural E; Ersoy F; Yalman N; Wulffraat N; Grillo E; Ozkinay F; Tezcan I; Gediköglu G; Philippe N; Fischer A; de Saint Basile G
Genomics; 2000 Feb; 63(3):299-306. PubMed ID: 10704277
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes.
Van Gele M; Geusens B; Schmitt AM; Aguilar L; Lambert J
J Invest Dermatol; 2008 Oct; 128(10):2474-84. PubMed ID: 18401430
[TBL] [Abstract][Full Text] [Related]
17. [Immunodeficiency and partial albinism, Griscelli syndrome].
Kawakami T; Mizoguchi M
Ryoikibetsu Shokogun Shirizu; 2000; (32):302-4. PubMed ID: 11212724
[No Abstract] [Full Text] [Related]
18. Griscelli syndrome: a model system to study vesicular trafficking.
Van Gele M; Dynoodt P; Lambert J
Pigment Cell Melanoma Res; 2009 Jun; 22(3):268-82. PubMed ID: 19243575
[TBL] [Abstract][Full Text] [Related]
19. Identification of a third myosin-5a-melanophilin interaction that mediates the association of myosin-5a with melanosomes.
Pan J; Zhou R; Yao LL; Zhang J; Zhang N; Cao QJ; Sun S; Li XD
Elife; 2024 Jun; 13():. PubMed ID: 38900147
[TBL] [Abstract][Full Text] [Related]
20. The dilute locus and Griscelli syndrome: gateways towards a better understanding of melanosome transport.
Westbroek W; Lambert J; Naeyaert JM
Pigment Cell Res; 2001 Oct; 14(5):320-7. PubMed ID: 11601653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
